Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy
Here we report the case of an 18-year-old woman with chronic myeloid leukemia (CML) who became pregnant while undergoing treatment with dasatinib. Before pregnancy, she received imatinib mesylate therapy but could not tolerate the treatment. The regimen was then changed to dasatinib at a dose of 70 ...
Saved in:
| Main Authors: | Monika Conchon, Sabri S. Sanabani, Mariana Serpa, Mafalda M. Y. Novaes, Luciana Nardinelli, Patrícia B. Ferreira, Pedro Enrique Dorliac-Llacer, Israel Bendit |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | Advances in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2010/136252 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of dasatinib in chronic myeloid leukemia therapy
by: O. Yu. Vinogradova, et al.
Published: (2008-12-01) -
Neutrophilic eccrine hidradenitis following dasatinib initiation in a patient with chronic myeloid leukemia
by: Avery Watson, M4, et al.
Published: (2025-07-01) -
Dasatinib-Induced Rhabdomyolysis in a 33-Year-Old Patient with Chronic Myeloid Leukemia
by: Andrew Stevenson Joel Chandranesan, et al.
Published: (2018-01-01) -
Dasatinib in core‐binding factor acute myeloid leukemia: A promising therapeutic approach
by: Shyam Srinivasan
Published: (2024-10-01) -
Dasatinib in First- and Second-Line Therapy of Chronic Myeloid Leukemia: Efficacy, Safety and Quality of Life
by: TI Ionova, et al.
Published: (2017-04-01)